The direct link between the BSE epidemic and the appearance of the new variant CJD (vCJD) in Europe caused by dietary exposure (Will et al., 1996<IMG BORDER=1 WIDTH=8 HEIGHT=7 ALT="Go"
SRC="/icons/fig-down.gif">; Scott et al., 1999<IMG BORDER=1 WIDTH=8 HEIGHT=7 ALT="Go"
SRC="/icons/fig-down.gif">) has heightened the urgency for development of therapeutic and prophylactic approaches against these fatal neurodegenerative disorders. So far, the common infectious agent causing these diseases appears to be a ss-sheet-rich and partially protease-resistant protein denoted PrPSc, derived from post-translational conversion of the -helical, protease-sensitive cellular prion protein (PrPc)
